Switzerland - Import of Heparin for Therapeutic Use
Since 2014, Switzerland Import of Heparin for Therapeutic Use decreased by 15.8% year on year. At $22,284,076 in 2019, the country was ranked number 22 comparing other countries in Import of Heparin for Therapeutic Use. Switzerland is overtaken by Denmark, which was ranked number 21 at $27,948,200 and is followed by Mexico at $19,922,628.21. France ranked the highest with $960,128,653.6 in 2019, a decrease of 6.6% compared to 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize recorded the best 5 years average growth at +183.7% per year, while Mauritania witnessed the worst performance at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 22,284,076.00 |
| 2018 | 55,924,184.00 |
| 2017 | 66,178,912.00 |
| 2016 | 24,867,414.00 |
| 2015 | 41,665,916.00 |
Download all data from 1988 to 2019
How does Switzerland rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 21 |
#21
Denmark
|
27,948,200.00 | 2019 | -15.9 % | -3.9 % | View data | |
| 22 |
#22
Switzerland
|
22,284,076.00 | 2019 | -60.1 % | -15.8 % | View data | |
| 23 |
#23
Mexico
|
19,922,628.21 | 2019 | +3.0 % | -1.3 % | View data | |